32nd Congress of the ESP and XXXIII International Congress of the IAP
(Glasgow) 2020: A Vision for the Future
6 - 8 December 2020 | now virtual
ESP website
32nd ESP Congress & XXXIII IAP Congress
Congress
ECP 2019 Nice
Presentations
Wednesday, 11 September 2019
Congress
Welcome Address
General Information
Downloads
Related Meetings / Media Partners
Committees & Organiser
CME Accreditation
Congress Newsletter
ECP 2019 Nice
Gallery
Awardees
Industry Partners
Presentations
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
FAQs
Abstracts
Guidelines for Submission
Bursaries
Format Descriptions
Registration
Registration Fees
Group Registration
Scientific Programme
Scientific Contents
Molecular Pathology Diagnostics Symposium
Computational Pathology Symposium
Sponsors & Exhibitors
General Information
Acknowledgements
My Account
Create Account
Congress Account
Sunday, 8 September 2019
Monday, 9 September 2019
Tuesday, 10 September 2019
Wednesday, 11 September 2019
Wednesday, 11 September 2019
08:30 - 12:00
SC-11 | Joint Session Cytopathology / Ophthalmic Pathology: From the eyes to the brain
SC-11-001-The use of cellient procedure for small tissue particles in cytology
SC-11-003-Aqueous/vitreous (uveitis vs lymphoma tumours) cytology
SC-11-004-The role of cytology in the diagnosis of ophthalmic lesions of the eyelid, conjunctiva and cornea
SC-11-005-CSF cytology
SPEC-04 | Special Session ESP & IAP: The case I will never forget
SPEC-04-002-Case 2
SPEC-04-005-Case 5
SPEC-04-006-Case 6
SPEC-05 | Taskforce Synoptic Reporting & ICCR: Synoptic reporting: to the next level
SPEC-05-001-Where are we going in 2020: update from the ICCR
SPEC-05-002-Not lost in translation!
SPEC-05-004-Molecular data in synoptic reports, part I: Canada
SPEC-05-005-Molecular data in synoptic reports, part II: the Netherlands
SS-13 | Joint Session Molecular Pathology and Trainees: Next generation pathology
SS-13-002-Case 1
SS-13-004-Case 3
SS-13-005-Case 4
SS-13-006-Case 5
SS-13-007-Case 6
SS-13-009-Case 8
SS-13-010-Case 9
SS-13-011-Case 10
SY-23 | Joint Session Uropathology & ESUP: An update on pathologic features of prostate and kidney carcinomas
SY-23-002-Novel and emerging pink (eosinophilic) renal tumours
SY-23-003-Cystic renal cell carcinoma in pathology practice
SY-23-004-Intra-operative assessment of RP surgical margins: the patients’ and pathologists’ view
SY-23-006-Molecular taxonomy of bladder cancer. Current status
SY-23-005-Molecular alterations for a molecular tumour board for prostate cancer patients
SY-24 | Joint Session Digestive Diseases Pathology & UEG: Challenging issues of post-treatment conditions in GI cancer pathology
SY-24-001-Endoscopic resection of gastrointestinal lesions and clinically challenging post-treatment conditions
SY-24-003-The wide range of drug related changes seen in gastrointestinal biopsies
SY-24-004-Current state and future perspectives of neoadjuvant treatment of gastrointestinal carcinomas
SY-24-005-Tumour regression grading - anything new?
SY-25 | Cardiovascular Pathology: Integrated morphologic and molecular approach to diagnosis of cardiovascular disease
SY-25-002-Pathology and genetics of Phospholamban cardiomyopathy
SY-25-003-Cardiomyopathies in neuromuscular disease
SY-25-004-Familial aortic dissection
SY-26 | History of Pathology: Colours of pathology: from H&E to molecular testing (+Business Meeting)
SY-26-001-Two hand in hand lovers on a glassy path: haematoxylin and eosin and histology
SY-26-004-Immunohistology: a historical perspective
14:00 - 16:00
SC-12 | Joint Session Cardiovascular Pathology / Autopsy Pathology: Autopsy investigations on the operated heart & vessels
SC-12-004-End stage heart disease: pathology of cardiac assist and replacement
SPEC-06 | Joint Session Papanicolaou Society of Cytology and French Society of Clinical Cytology: From morphology to the ancillary techniques and molecular cytopathology
SPEC-06-001-Head and neck cytology specimens: HPV testing and p16 staining
SPEC-06-002-Salivary glands cytology: morphology, FISH and NGS
SPEC-06-004-Effusions: morphology, immunocytochemistry and molecular cytopathology
SPEC-06-005-Pancreaticobiliary cytology: morphology, FISH and NGS
SPEC-07 | Pathology & Public Task Force: Pathology and public
SPEC-07-001-Pathology and EU affairs: the formalin ban case
SPEC-07-002-Students' perception of pathology in everyday medical practice
SPEC-07-003-Pathology and Public: the perspective of a resident
SPEC-07-004-Pathology and Public: what a pathologist can do!
SPEC-07-005-Pathology without frontiers: the human face of pathology
SPEC-07-006-Science and art through the microscope
SPEC-07-007-Pathology and Public Task Force: can we do better?
SS-14 | Joint Session Soft Tissue and Bone Pathology / Ophthalmic Pathology: More than meets the eyes
SS-14-001-Case 1
SS-14-002-Case 2
SS-14-003-Case 3
SS-14-004-Case 4
SS-14-005-Case 5
SS-14-006-Case 6
SS-14-007-Case 7
SY-27 | Joint Session Endocrine Pathology / Uropathology: Update on endocrine/neuroendocrine neoplasms of the adrenal gland and urogenital system
SY-27-001-Similarity and differences among neuroendocrine tumours of the kidney
SY-27-002-Neuroendocrine tumours of the prostate: from morphology to molecular perspective
SY-27-003-The spectrum of neuroendocrine neoplasms of the urinary bladder
SY-27-004-New diagnostic guidelines for adrenocortical carcinoma
SY-27-005-Sporadic and familial pheochromocytoma: an update
SY-28 | Digestive Diseases Pathology: Immune-related hepato-biliary and pancreatic disorders: Update of old classifications and new disease entities
SY-28-002-Drug-related liver injury due to immunocheckpoint inhibitors and drugs used in the therapy of autoimmune hepatitis
SY-28-004-Autoimmune pancreatitis
SY-29 | National Societies: (Re)certification in pathology - a reality or an illusion?
SY-29-002-Talk 2
SY-29-003-Talk 3
SY-29-004-Talk 4
SY-29-005-Talk 5
SY-29-006-Talk 6
SY-29-007-Talk 7
SY-29-008-Talk 8
SY-30 | Joint Session Pathology in Favour of Developing Countries / History of Pathology / Infectious Diseases Pathology: Pathology of migration or migration of pathologies?
SY-30-001-Introduction to the session by ESP President
SY-30-002-When migrants were Europeans: a lesson to remember from the past
SY-30-003-Mines and illness: the price to pay for raw materials
SY-30-004-The role of communicable diseases in present migrations
TR-01 | Trainees' Session: Residencies across Europe: realities, problems and future perspectives
TR-01-001-UEMS activity, EU Pathology training requirements, and EU Board of Pathology
TR-01-002-Molecular pathology in the Polish residency: realities, problems and future perspectives
TR-01-003-The ESP/UEMS pathology progress test: how does it contribute to harmonisation of training outcome?
TR-01-004-The residency in Spain: realities, problems and future perspectives
TR-01-005-The Dutch model
TR-01-006-The residency in the Netherlands: realities, problems and future perspectives
TR-01-007-The role of sub-specialisation in the training of pathology in Europe
TR-01-008-The residency in France: realities, problems and future perspectives
TR-01-010-The current state of post-graduate training in Europe: data from a survey with a review of the literature
16:30 - 17:15
KL-04 | Keynote Lecture by Pierre Bedossa
KL-04-001-Liver fibrosis revisited
17:15 - 18:45
PL-01 | Plenary OFP Session
PL-01-001-Expression of the inhibitory receptor CD94/NKG2A on CD8+ tumour-infiltrating lymphocytes in colorectal cancer: a new promising druggable immune checkpoint in a context of HLA-E/b2microglobuline overexpression by tumour cells
PL-01-002-Significant inter- and intra-laboratory variation in grading of invasive breast cancer: a nationwide study of 33,043 patients in the Netherlands
PL-01-003-A gene expression signature of microvascular invasion in hepatocellular carcinoma in formalin fixed-paraffin embedded biopsies
PL-01-006-Features of PLAP expression in placental structures during allogeniec pregnancy (surrogate maternity, oocyte donation) on the background of pre-eclampsia, as an indicator of exosomal trophoblast activity
PL-01-007-XIST promoter methylation status as putative molecular biomarker for testicular germ cell tumours
PL-01-008-Progenitor cells in ovario-fimbrial zone of female uterine adnexa: a potential clue for epithelial tumours pathogenesis